Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

about

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.

P2860

Q36060239-CDD7437D-D9E2-4949-87C2-2FE8A2A86803 Q41942675-9F98B8E7-3FA8-466E-837F-231BEE2B99EC

P2860

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

Item

http://www.wikidata.org/entity/Q36911495

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

@en

type

Item

label

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

@en

prefLabel

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

@en

P1476

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

@en

P2093

Corradini Paolo

http://www.w3.org/2001/XMLSchema#string

Dodero Anna

http://www.w3.org/2001/XMLSchema#string

Farina Lucia

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents.

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

P304

1496-1501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190701435275

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17701579

http://www.w3.org/2001/XMLSchema#string

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

about

P2860

P2860

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698